GSEA plot shows SCLC downregulated signature genes are significantly enriched in upregulated genes upon iBAP-II treatment, while SCLC upregulated signature genes are significantly enriched in downregulated genes with iBAP-II treatment (Supplementary Fig. 4I). The gene discussed is FABP6; the disease is small cell lung carcinoma.